TrademarkDir
CTX131
DEAD

Serial Number

97371566

Owner

CRISPR Therapeutics AG

Attorney

Tiffany D. Gehrke

First Use Date

Mar 27, 2023

Filing Date

Apr 20, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CTX131 Trademark

Serial Number: 97371566

CTX131 is a trademark filed by CRISPR Therapeutics AG on April 20, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

CRISPR Therapeutics AG (50 trademarks)

ZUG V8 6300 , CH

Entity Type: 99

Trademark Details

Filing Date

April 20, 2022

Registration Date

Not Registered

First Use Anywhere

March 27, 2023

First Use in Commerce

March 27, 2023

Published for Opposition

April 23, 2024

Goods & Services

Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of CAR T cell therapy for the treatment of hematologic malignancies; gene editing, namely, pharmaceutical research and development in the field of CAR T cell therapy for the treatment of hematologic malignancies

Cells for medical or clinical use in the field of CAR T cell therapy for the treatment of hematologic malignancies; pharmaceutical and biopharmaceutical agents for the treatment of cancer in the field of CAR T cell therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer in the field of CAR T cell therapy

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 15, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 15, 2026 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Sep 30, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Sep 30, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 3, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 3, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jul 3, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 6, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 6, 2025 CRFA
ASSIGNED TO LIE
Jun 6, 2025 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 29, 2025 TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 28, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 5, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 5, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
Mar 5, 2025 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Feb 12, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 12, 2025 AITU
USE AMENDMENT FILED
Dec 2, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 2, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 18, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 23, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 3, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 15, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 16, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 16, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 16, 2024 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 18, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 18, 2023 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 2, 2023 GNFN
FINAL REFUSAL E-MAILED
Oct 2, 2023 GNFR
FINAL REFUSAL WRITTEN
Oct 2, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 11, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 10, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 10, 2023 TROA
ASSIGNED TO EXAMINER
Jul 3, 2023 DOCK
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 11, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 11, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 14, 2023 GNRN
NON-FINAL ACTION E-MAILED
Feb 14, 2023 GNRT
NON-FINAL ACTION WRITTEN
Feb 14, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 7, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 26, 2022 NWOS
NEW APPLICATION ENTERED
Apr 23, 2022 NWAP

Related Trademarks

More from this Owner

CTX321

CTX321

CTX611

CTX611

CTX213

CTX213

CRISPR-X

CRISPR-X

CTX460

CTX460

CTX460

CTX460